Q192R polymorphism of paraoxonase 1 gene associated with insulin resistance in Mexican children

Arch Med Res. 2015 Jan;46(1):78-83. doi: 10.1016/j.arcmed.2014.12.001. Epub 2014 Dec 10.

Abstract

Background and aims: The SNP rs662 in the paraoxonase 1 gene (PON1 Q192R) has been associated with obesity, dyslipidemia and cardiovascular risk. In this study, DNA samples of 117 children aged 6 to 12 years from San Luis Potosí, México were genotyped for Q192R polymorphism of the PON1 gene.

Methods: Genotypic frequencies were determined by allelic discrimination assay by real-time PCR using TaqMan fluorogenic probes. Anthropometry, lipid profile, glucose and insulin were analyzed by genotype.

Results: The distribution of allele frequency in the population was Q = 65 and R = 35 following the Hardy Weinberg equilibrium (χ(2) = 3.15, p = 0.076). The Homeostasis Model Assessment for Insulin Resistance (HOMA-IR) index showed statistically significant differences among QQ/QR/RR genotypes (p = 0.032). The odds ratio for the carriers of the RR genotype was associated with HOMA-IR corresponding to the 95(th) percentile or higher for Mexican children based on sex and age (OR = 4.68; 95% confidence intervals, 1.23-17.8; p = 0.016). When the absolute mean of HOMAR-IR was set as the cutoff, an increased odds was observed (OR = 6.52; 95% confidence intervals, 1.68-25.3; p = 0.008).

Conclusions: According to our results, PON1 Q192R polymorphism is a risk marker for insulin resistance, a pathological factor involved in the development of metabolic syndrome.

Keywords: Insulin resistance; Metabolic syndrome; Obesity; PON 1 gene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aryldialkylphosphatase / genetics*
  • Cardiovascular Diseases / genetics
  • Child
  • Dyslipidemias / genetics
  • Female
  • Gene Frequency
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Insulin Resistance / genetics*
  • Male
  • Metabolic Syndrome / genetics
  • Mexico
  • Obesity / genetics
  • Polymorphism, Single Nucleotide
  • Real-Time Polymerase Chain Reaction
  • Risk
  • Risk Factors

Substances

  • Genetic Markers
  • Aryldialkylphosphatase
  • PON1 protein, human